Prothena will cut 63% of its workforce and evaluate a “range of business options.” Elsewhere, Zealand revealed data for a ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

Smith & Wesson Brands reported falling profit and sales as consumers become more cautious. The gunmaker's CEO, Mark Smith, ...

Genentech, part of the Roche Group (OTCQX:RHHBY), said that a late-stage study testing Lunsumio, along with Polivy, showed ...